Director Phillip R. Cabrera of Byline Bancorp (NYSE: BY) executed a purchase of 169 shares of the bank's common stock on January 28, 2026. The shares were acquired at $31.03 apiece, bringing the aggregate cost of this transaction to $5,244.
Following the transaction, Cabrera's direct ownership of Byline Bancorp stands at 15,871 shares. In addition to those direct holdings, he has an indirect stake of 4,129 shares held through the Phillip R. Cabrera Revocable Trust.
The timing of Cabrera's purchase coincides with the release of Byline Bancorp's fourth-quarter 2025 financial results, which surpassed consensus expectations. The company reported earnings per share of $0.76, beating the projected $0.72 estimate, a surprise of 5.56% versus forecast. Revenue for the quarter was $117 million, ahead of the expected $112.31 million, representing a 4.18% surprise to the upside.
Market analysts took note of the quarterly performance. Piper Sandler responded by raising its price target for Byline Bancorp to $37 from $35 while maintaining an Overweight rating on the stock. The firm cited a 9% pre-provision net revenue upside as a key factor behind its action. That upside was attributed to stronger-than-expected core fee income and net interest income, together with an unanticipated expansion in net interest margin during the quarter.
These reported results and the subsequent analyst adjustment are presented by the company and observers as indicators of Byline Bancorp's financial strength and operational efficiency for the most recent quarter.
Transaction details - at a glance
- Buyer: Phillip R. Cabrera, director
- Shares purchased: 169
- Price per share: $31.03
- Total transaction value: $5,244
- Transaction date: January 28, 2026
- Direct holdings after purchase: 15,871 shares
- Indirect holdings (Phillip R. Cabrera Revocable Trust): 4,129 shares
Quarterly performance summary
- Q4 2025 EPS: $0.76 vs. $0.72 expected (5.56% surprise)
- Q4 2025 Revenue: $117 million vs. $112.31 million expected (4.18% surprise)
- Analyst action: Piper Sandler raised price target to $37 from $35; Overweight rating maintained
- Piper Sandler rationale: 9% pre-provision net revenue upside driven by stronger core fee income and net interest income, and an unexpected net interest margin expansion